Peptides for low testosterone: what the evidence shows

Do peptides help with male hypogonadism (low testosterone)?

3 peptides are graded for male hypogonadism (low testosterone) on this page. The strongest grade is human RCT evidence, for HCG (human chorionic gonadotropin). Each one is weighed against the standard of care below, and the evidence table gives the grade and a note for every peptide.

What is the standard of care for male hypogonadism (low testosterone)?

Confirm with two early morning total testosterone levels below the reference range plus consistent symptoms; measure LH, FSH, and prolactin to find the cause; testosterone therapy for men not seeking fertility; hCG, with FSH if needed, for men with secondary hypogonadism who want fertility, because testosterone suppresses sperm production.

Any peptide below should be judged against this baseline, not against doing nothing. Talk to a licensed provider before replacing or adding to an established treatment.

Which peptides have been studied for male hypogonadism (low testosterone)?

Ordered by strength of evidence for this use. Grades follow the methodology; each peptide page lists the individual studies.

Peptides studied for Male hypogonadism (low testosterone) with evidence grades
Peptide	Evidence for this use	Note
HCG (human chorionic gonadotropin)	Evidence: Human RCT evidence	FDA approved for hypogonadotropic hypogonadism in males; in a 26 man retrospective series, low dose hCG with testosterone maintained semen parameters for over a year. [2] [3] [5]
Gonadorelin	Evidence: Human observational evidence	Pulsatile GnRH induced sperm in 54 of 57 treatment courses in men with hypogonadotropic hypogonadism, similar to hCG plus hMG; branded US products were discontinued. [2] [3] [6]
Kisspeptin-10	Evidence: Human observational evidence	Daily infusions raised LH, FSH, and testosterone for 12 days in 27 healthy men; experimental and not approved. [4]

Head-to-head comparisons

Cost and access

Price ranges, lawful channels, and insurance notes for peptides graded here. State rules are in the legal guides by state.

Frequently asked questions

Are there peptides for low testosterone?

Yes, for specific cases. hCG is FDA approved for hypogonadotropic hypogonadism in men and is used when fertility matters, because testosterone therapy suppresses sperm production. Pulsatile GnRH (gonadorelin) restored sperm production in most treatment courses in older studies, but branded US products were discontinued. Kisspeptin raised testosterone for 12 days in healthy men and remains experimental. Testosterone therapy is the standard treatment for men not seeking fertility. [1] [3] [4] [5] [6]

Does hCG raise testosterone?

Yes, in men whose testes can respond. hCG acts like luteinizing hormone and stimulates the testes to make testosterone, which is why it is FDA approved for hypogonadotropic (secondary) hypogonadism in males. The Endocrine Society guideline reserves gonadotropin therapy for secondary hypogonadism, not for primary testicular failure. [1] [5]

Is any peptide FDA approved for male hypogonadism (low testosterone)?

HCG (human chorionic gonadotropin) and gonadorelin are FDA approved drugs, but an approval covers only the indications on that label, so check the label before assuming it applies to male hypogonadism (low testosterone). The other peptides graded here are not FDA approved. [2] [3] [5] [6]

Has any peptide been tested in a randomized trial for male hypogonadism (low testosterone)?

Yes, for HCG (human chorionic gonadotropin). Check each note for the population and endpoints: a randomized trial in a related group or on a surrogate marker is weaker than one on the outcome you care about. [2] [3] [5]

From the blog

Peptides for men, ranked by human evidence
hCG, GLP-1 drugs, teriparatide, and tesamorelin have human trials and a lawful route. PT-141 is off-label for men, and kisspeptin and melanotan II have no lawful path. Ranking, legality, and WADA.